• 1. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Alkyl halides Cyclohexyl halides

Comprehensive Overview of tert-Butyl 4,4-difluorocyclohexylcarbamate (CAS No. 675112-67-1)

tert-Butyl 4,4-difluorocyclohexylcarbamate (CAS No. 675112-67-1) is a fluorinated carbamate derivative that has garnered significant attention in pharmaceutical and agrochemical research. This compound, characterized by its tert-butyl and difluorocyclohexyl moieties, is widely utilized as a key intermediate in the synthesis of bioactive molecules. Its unique structural features, including the 4,4-difluorocyclohexyl ring, contribute to enhanced metabolic stability and lipophilicity, making it a valuable building block in drug discovery.

In recent years, the demand for fluorinated compounds like tert-Butyl 4,4-difluorocyclohexylcarbamate has surged due to their applications in developing targeted therapies and precision agriculture. Researchers are particularly interested in its role as a protease inhibitor precursor or kinase modulator, aligning with the growing focus on personalized medicine. The compound's carbamate group also offers versatility in prodrug design, a hot topic in AI-driven drug development.

The synthesis of CAS 675112-67-1 typically involves multi-step organic reactions, including Boc protection and fluorination strategies. Analytical techniques such as HPLC, NMR, and mass spectrometry are employed to ensure high purity, addressing the pharmaceutical industry's stringent quality control requirements. This aligns with current GMP compliance trends and the search for reliable chemical suppliers in online queries.

From an environmental perspective, the difluorocyclohexyl structure demonstrates improved biodegradability compared to perfluorinated compounds, responding to increasing concerns about PFAS alternatives. This positions tert-Butyl 4,4-difluorocyclohexylcarbamate as a more sustainable option in green chemistry applications, a frequently searched topic in academic databases and industry forums.

In material science, the compound's thermal stability (often analyzed via DSC) makes it suitable for high-performance polymers. Its crystallinity properties are being explored for electronic materials, coinciding with rising interest in organic semiconductors—a trending search term in scientific literature and patent analyses.

Regulatory databases show that 675112-67-1 is compliant with major REACH and FDA guidelines for research use, though proper risk assessment protocols must be followed. This addresses common queries about chemical safety data sheets and lab handling procedures in search engines. The compound's storage conditions (typically 2-8°C under inert atmosphere) are frequently documented in technical bulletins.

Market analyses indicate growing procurement of tert-Butyl 4,4-difluorocyclohexylcarbamate by CROs and CDMOs, reflecting the expansion of contract research services. This correlates with search trends for custom synthesis and scale-up solutions in the pharmaceutical outsourcing sector. The compound's price fluctuations are often monitored through chemical market intelligence platforms.

Recent patent landscaping reveals applications of this intermediate in cancer immunotherapy and neurodegenerative disease research, areas dominating biomedical publications. Its structure-activity relationships (SAR) are frequently modeled using computational chemistry tools, matching the surge in AI-assisted molecular design searches.

For analytical purposes, the compound's chromatographic behavior (typically reversed-phase C18 columns) and fragmentation patterns in LC-MS are well-documented, addressing common laboratory technique queries. Its UV absorption characteristics facilitate detection in high-throughput screening systems.

In conclusion, tert-Butyl 4,4-difluorocyclohexylcarbamate (CAS 675112-67-1) represents a multifaceted compound bridging medicinal chemistry, materials science, and sustainable technology. Its evolving applications continue to inspire cross-disciplinary research, making it a persistent subject in scientific queries and industrial innovation discussions.

• 2060029-38-9(tert-butyl N-(3,3-difluorocyclohexyl)carbamate)
• 1448310-30-2(tert-butyl N-(4-fluorocyclohexyl)carbamate)
• 1215071-23-0(tert-butyl N-(3,3-difluorocyclopentyl)carbamate)
• 1029720-19-1(tert-butyl N-(3,3-difluorocyclobutyl)carbamate)
• 1546332-14-2(Tert-butyl N-(3-fluorocyclohexyl)carbamate)
• 1422966-97-9(Tert-butyl (4-fluorocyclohexyl)carbamate)
• 1779125-53-9(Tert-Butyl N-{6,6-difluorospiro[2.5]octan-1-yl}carbamate)
• 921599-71-5(Tert-Butyl (2,2-difluorocyclopentyl)carbamate)
• 921602-82-6(tert-butyl 2,2-difluorocyclohexylcarbamate)
• 809273-64-1(Carbamic acid, [(4,4-difluorocyclohexyl)methyl]-, 1,1-dimethylethyl ester)